Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 11, Issue 8, Pages 1181-1192
Publisher
Informa UK Limited
Online
2011-08-26
DOI
10.1586/era.11.93
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals
- (2014) Terence O'Reilly et al. Translational Oncology
- Sirolimus and tuberous sclerosis-associated renal angiomyolipomas
- (2010) L. Krischock et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges
- (2010) Romina Moavero et al. CHILDS NERVOUS SYSTEM
- Tuberous sclerosis complex: a brave new world?
- (2010) Kevin C Ess CURRENT OPINION IN NEUROLOGY
- New inhibitors of the mammalian target of rapamycin signaling pathway for cancer
- (2010) Sébastien Albert et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New roles for Notch in tuberous sclerosis
- (2010) Warren S. Pear JOURNAL OF CLINICAL INVESTIGATION
- Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade
- (2010) Jianhui Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex
- (2010) Ala Birca et al. Journal of Neurosurgery-Pediatrics
- Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex
- (2010) R. Peces et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diffusion Features of White Matter in Tuberous Sclerosis With Tractography
- (2010) Michelle L. Krishnan et al. PEDIATRIC NEUROLOGY
- Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity
- (2010) Michael Haidinger et al. TRANSPLANT INTERNATIONAL
- Current trends in the treatment of infantile spasms
- (2010) Chang-Yong Tsao Neuropsychiatric Disease and Treatment
- Perinatal (Fetal and Neonatal) Tuberous Sclerosis: A Review
- (2009) Hart Isaacs AMERICAN JOURNAL OF PERINATOLOGY
- The tuberous sclerosis complex
- (2009) Ksenia A. Orlova et al. Annals of the New York Academy of Sciences
- Therapeutic targeting of mTOR in tuberous sclerosis
- (2009) Julian R. Sampson BIOCHEMICAL SOCIETY TRANSACTIONS
- Dissecting the role of mTOR: Lessons from mTOR inhibitors
- (2009) Ryan J.O. Dowling et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated
- (2009) Prasanna Sooriakumaran et al. BJU INTERNATIONAL
- Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies
- (2009) Michael Wong EPILEPSIA
- Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature
- (2009) M. E. A. P. M. Adriaensen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Attention-Deficit Hyperactivity Disorder (ADHD) and Tuberous Sclerosis Complex
- (2009) Elisa D'Agati et al. JOURNAL OF CHILD NEUROLOGY
- Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis
- (2009) Kristen Pollizzi et al. Molecular Cancer
- Cardiac Rhabdomyomas in Tuberous Sclerosis Complex Show Apoptosis Regulation and mTOR Pathway Abnormalities
- (2009) Katarzyna Kotulska et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors
- (2009) Catherine Lam et al. PEDIATRIC BLOOD & CANCER
- Rapamycin as a Therapy of Choice After Renal Transplantation in a Patient With Tuberous Sclerosis Complex
- (2009) A. Tarasewicz et al. TRANSPLANTATION PROCEEDINGS
- Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
- (2008) Ling-Hui Zeng et al. ANNALS OF NEUROLOGY
- Recent advances in neurobiology of Tuberous Sclerosis Complex
- (2008) Valerio Napolioni et al. BRAIN & DEVELOPMENT
- mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?
- (2008) C Le Tourneau et al. BRITISH JOURNAL OF CANCER
- The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
- (2008) G.F.L. Hofbauer et al. BRITISH JOURNAL OF DERMATOLOGY
- Lymphangioleiomyomatosis
- (2008) Francis X. McCormack CHEST
- Genetics and Molecular Biology of Tuberous Sclerosis Complex
- (2008) Valerio Napolioni et al. CURRENT GENOMICS
- Are cortical tubers epileptogenic? Evidence from electrocorticography
- (2008) Philippe Major et al. EPILEPSIA
- Behavior problems in children with tuberous sclerosis complex and parental stress
- (2008) Claudine M.C. Kopp et al. EPILEPSY & BEHAVIOR
- Deforolimus (AP23573) a novel mTOR inhibitor in clinical development
- (2008) Monica Mita et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Management of epilepsy in tuberous sclerosis complex
- (2008) P Curatolo et al. Expert Review of Neurotherapeutics
- Tuberous sclerosis complex proteins control axon formation
- (2008) Y.-J. Choi et al. GENES & DEVELOPMENT
- Regression of Subependymal Giant Cell Astrocytoma With Rapamycin in Tuberous Sclerosis Complex
- (2008) Mary Kay Koenig et al. JOURNAL OF CHILD NEUROLOGY
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
- (2008) L. Meikle et al. JOURNAL OF NEUROSCIENCE
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Sirolimus Therapy in Tuberous Sclerosis or Sporadic Lymphangioleiomyomatosis
- (2008) D. Mark Davies et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Sirolimus in Treating Tuberous Sclerosis and Lymphangioleiomyomatosis
- (2008) Elahna Paul et al. NEW ENGLAND JOURNAL OF MEDICINE
- The pathogenesis and imaging of the tuberous sclerosis complex
- (2008) Henry J. Baskin PEDIATRIC RADIOLOGY
- Tolerance Profile of the Proliferation Signal Inhibitors Everolimus and Sirolimus in Heart Transplantation
- (2008) J.A. Moro et al. TRANSPLANTATION PROCEEDINGS
- Current Management of Tuberous Sclerosis Complex
- (2008) Darcy A Krueger et al. PEDIATRIC DRUGS
- Role of mTOR in physiology and pathology of the nervous system
- (2007) Lukasz Swiech et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Mechanisms of Epileptogenesis in Tuberous Sclerosis Complex and Related Malformations of Cortical Development with Abnormal Glioneuronal Proliferation
- (2007) Michael Wong EPILEPSIA
- Cardiac rhabdomyoma in tuberous sclerosis: Hyperactive Erk signaling
- (2007) Jaroslaw Jozwiak et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started